Searched for
HIV MEDICINES
Anthropic appoints Indian-origin Novartis CEO Vas Narasimhan to its boardAnthropic’s Long-Term Benefit Trust is an independent governance body, designed to insulate key decisions as it scales its frontier AI syst...- Trump admin set to destroy vital HIV meds and contraceptives worth $12 million following closure of USAIDThe Trump government may destroy $12 million worth of HIV and birth control medicines bought to help poor countries. These medicines are st...
- New HIV cases down by 44% since 2010: Anupriya PatelNew annual HIV infections in India have decreased by 44 per cent since 2010, surpassing the global reduction rate of 39 per cent. Union Min...
- HIV treatment: Can cancer medicine cure HIV patients? Here's what researchers, doctors have foundScientists at a Melbourne research institute in Australia have found that a medicine used to treat blood cancer can kill HIV cells. Know in...
- Pharma department tells companies to step up manufacture of anti-HIV drugsExperts meets pharma execs seeking enough stock of Lopinavir and Ritonavir to be kept ready for India.
- Payment delays by NACO causing HIV drugs scarcityCipla, the sole producer of lopinavir/ritonavir, a combination HIV drug prescribed for paediatric patients, has stopped manufacturing it ov...
- Activists cry foul over new HIV drug monopolyOnly one Indian drug maker, Emcure, will be allowed to sell the medicine in the Indian private market, because of a licensing agreement wit...
- New drug may prevent HIV transmission in women, kidsUp to 45 per cent of HIV-infected mothers will transmit the virus to their child, usually through breastfeeding, researchers said.
- 80% drugs to combat AIDS supplied by India: JP NaddaThe UN General Assembly adopted a new political declaration that emphasised on the critical importance of affordable medicines to combat th...
- How modern medicine is keeping HIV in checkThe stigma of HIV remains. But with modern medicines, Charlie Sheen and others infected by the virus can lead a normal life.
- New HIV infections down by 20 per cent in India: UN reportIndia has been able to achieve a more than 20% decline in new HIV infections between 2000 and 2014, according to a UN report.
- Anti-AIDS medicine project likely to take off at SonagachiUnder the project PrEP, regular medicine would be given to an HIV-negative sex worker engaged in sex with an HIV-positive person.
- Cipla, Aurobindo, Emcure to supply HIV drugs for UN-backed programmeAurobindo Pharma Chief Executive Officer said the new licence would help ensure the timely introduction of generic ATV in developing countr...
- Shilpa Medicare inks pact with MPP, Gilead for HIV/AIDS drugsShilpa Medicare inked an agreement with Gilead Sciences to increase access to medicines used for treatment of HIV/AIDS.
- Strides Arcolab inks pact with Gilead Sciences to promote HIV drugStrides has inked a pact with Gilead Sciences Inc to sell low-cost generic versions of latter's HIV medicine 'emtricitabine' in developing ...
- Gilead Sciences inks deals with 3 Indian companies including Ranbaxy Laboratories for low-cost HIV drugGilead Sciences has signed deals with 3 Indian firms to collaborate on promoting access to HIV medicine emtricitabine in developing nations.
- Hetero Labs to produce Gilead's HIV drugs, through Medicines Patent PoolHyderabad based Hetero labs through an agreement with Geneva based Medicines Patent Pool will produce four key HIV drugs developed by Gilea...
- AIDS groups criticise US/EU/Japan for putting profits of MNC drug makers before patientsPatient advocacy and civil society groups working in the area of HIV/AIDS have criticized free trade agreements (FTAs) being signed between...
- Bristol-Myers patent plea for HIV drug rejectedIndia has rejected American drugmaker Bristol-Myers Squibb's (BMS) patent application for one of its HIV drugs, allowing local drugmakers t...
- Abbott patent application for HIV drug spurnedBesides I-MAK, a few local HIV drug makers such as Cipla and US-based Mylan-owned Matrix Laboratories had also opposed Abbott's attempt to ...
Load More
